Your search returned 11 results.

Results
	1.	Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature. MedStar authors: Zaemes, Jacob PMID: 32375103 Year: 2020 Citation: European Journal of Cancer. 132:168-175, 2020 06. Department: MedStar Georgetown University Hospital Residents Medline publication type: Journal Article Form of publication: Journal Article All authors: Kim C, Zaemes J DOI: https://dx.doi.org/10.1016/j.ejca.2020.03.015 https://dx.doi.org/10.1016/j.ejca.2020.03.015 https://dx.doi.org/10.1016/j.ejca.2020.03.015 https://dx.doi.org/10.1016/j.ejca.2020.03.015 Add to cart (remove)
	2.	Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. MedStar authors: Barac, Ana Forrestal, Brian J PMID: 32029128 Year: 2020 Citation: Journal of the American College of Cardiology. 75(5):467-478, 2020 02 11. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Alvi RM, Awadalla M, Bakar RB, Banerji D, Barac A, Chen CL, Cohen JV, Devereux RB, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Hung J, Jones-O'Connor M, Kirchberger MC, Lawrence DP, Liu S, Lyon AR, Mahmood SS, Mahmoudi M, Mandawat A, Mercaldo ND, Mulligan CP, Murphy SP, Neilan TG, Nohria A, Picard MH, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Shah SP, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Zhang L, Zlotoff DA DOI: https://dx.doi.org/10.1016/j.jacc.2019.11.049 Add to cart (remove)
	3.	Risk of cardiovascular adverse events from trastuzumab (Herceptin()) in elderly persons with breast cancer: a population-based study. MedStar authors: Barac, Ana PMID: 24469642 Year: 2014 Citation: Breast Cancer Research & Treatment. 144(1):163-70, 2014 Feb. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Form of publication: Journal Article All authors: Barac A, Freedman AN, Fu AZ, Huang CY, Isaacs C, Potosky AL, Tsai HT, Warren JL DOI: http://dx.doi.org/10.1007/s10549-014-2836-7 Add to cart (remove)
	4.	Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study). MedStar authors: Barac, Ana PMID: 30538037 Year: 2019 Citation: American Journal of Cardiology. 123(4):667-673, 2019 02 15. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Abbas SA, Barac A, Desai R, Durairaj A, Fong HK, Goyal H, Hung O, Kumar G, Sachdeva R, Yusuf SW DOI: https://dx.doi.org/10.1016/j.amjcard.2018.11.006 Add to cart (remove)
	5.	Vemurafenib-induced DRESS. MedStar authors: Jang, Sekwon Nasabzadeh, Teresa Pichard, Dominique C Wenk, Kurt S PMID: 23986488 Year: 2013 Citation: JAMA Dermatology. 149(10):1242-3, 2013 Oct. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Dermatology Medline publication type: Case Reports Journal Article Form of publication: Journal Article All authors: Jang S, Nasabzadeh T, Pichard DC, Venna SS, Wenk KS DOI: http://dx.doi.org/10.1001/jamadermatol.2013.5278 Add to cart (remove)
	6.	Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer. MedStar authors: Carvalho, Filipe Egan, Jillian Hwang, Jonathan J Krasnow, Ross Lynch, John H Stamatakis, Lambros Zeymo, Alexander PMID: 32665995 Year: 2020 Citation: Investigative And Clinical Urology. 61(4):390-396, 2020 07. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Urology Medline publication type: Journal Article Form of publication: Journal Article All authors: Carvalho FL, Egan J, Hwang J, Kelly CH, Kowalczyk KJ, Krasnow RE, Lynch JH, Stamatakis L, Zeymo A, Zheng C DOI: https://dx.doi.org/10.4111/icu.2020.61.4.390 Add to cart (remove)
	7.	Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors: Herbolsheimer, Pia M Jelinek, James S Kapoor, R Perry, David J Smith, Karen L Swain, Sandra M Verma, Nitin Veytsman, Irina PMID: 22392508 Citation: Investigational New Drugs. 31(1):92-8, 2013 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Radiology Medline publication type: Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I DOI: http://dx.doi.org/10.1007/s10637-012-9805-y Add to cart (remove)
	8.	Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors: Blackburn, Matthew J Lynce, Filipa PMID: 29119354 Year: 2018 Citation: Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H DOI: https://dx.doi.org/10.1007/s10549-017-4563-3 Add to cart (remove)
	9.	Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors: Priebat, Dennis A PMID: 31900276 Year: 2020 Citation: Clinical Cancer Research. 26(6):1258-1266, 2020 03 15. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA DOI: https://dx.doi.org/10.1158/1078-0432.CCR-19-1824 Add to cart (remove)
	10.	Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors: Rao, Suman PMID: 30620668 Year: 2019 Citation: Journal of Clinical Oncology. 37(7):537-546, 2019 03 01. Institution: Medstar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J DOI: https://dx.doi.org/10.1200/JCO.18.00149 Add to cart (remove)
	11.	Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. MedStar authors: Barett, Christina Bikas, Athanasios Burman, Kenneth D Clark, Brandon G Desale, Sameer Gandhi, Rahul Jelinek, James S Kundra, Priya Mete, Mihriye O'Keefe, Kaitlyn Wartofsky, Leonard Wexler, Jason Wray, Lynette PMID: 26671977 Year: 2016 Citation: European Journal of Endocrinology. 174(3):373-80, 2016 Mar. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Radiology Medline publication type: Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barett C, Bikas A, Burman KD, Clark BG, Desale S, Gandhi R, Jelinek JS, Kundra P, Mete M, O'Keefe K, Wartofsky L, Wexler JA, Wray L DOI: http://dx.doi.org/10.1530/EJE-15-0930 Add to cart (remove)

Powered by Koha